radioterapie.eu

Gynecologic Oncology · v0.1.0-preview.1

Build the case as a clinical story

Site-first navigation, chronological case intake, medical-oncology decision drivers, RT/brachy workspace and point-of-use teaching.

PREVIEWExecutable systemic-therapy slices are source-bounded and require clinical review.
No patient identifiers. This preview does not save cases to WordPress. Use age band / clinical facts only.
CASE INTAKE

Tell the story in the order it happened

1Where are we in the story?This changes which later questions matter.
2How did the disease present?Start with the reason the patient entered the pathway.
3How was cancer confirmed?Pathology before treatment assumptions.
Histology and grade determine which staging, molecular and treatment branches are even applicable.
4What is the extent of disease?Imaging, local extension, nodes, distant disease, then stage.
5What does the tumour biology add?Only decision-driving biomarkers appear for the selected site/episode.
6What has already happened?Surgery, RT/brachy and systemic therapy form a treatment timeline.
7What is happening now?Current burden, tempo and symptoms—not historical stage alone.
8Can the proposed treatment be given safely?Recommendation is not prescription readiness.
Clinical Safety handoffAny regimen remains NOT READY TO PRESCRIBE until drug-specific prerequisites, organ-function thresholds, overlapping toxicities and monitoring are checked.Open Clinical Safety
9What decision are we making today?The output should answer this question—not every possible question.
RADIOTHERAPY / BRACHYTHERAPY

EQD2 summation workspace

Custom calculation only in v0.1; no unsourced prescription presets or OAR constraints are encoded yet.

Tumour / acute α/β 10—
Late OAR α/β 3—
How is this calculated?

Linear-quadratic EQD2 = D × (d + α/β) / (2 + α/β), calculated separately for EBRT and brachytherapy and then summed for the selected α/β. Physical doses are never simply added as biologically equivalent doses.